New research suggests that men with prostate cancer who choose radiation therapy should seek treatment centers that will offer high-dose radiation. A new study from Fox Chase Cancer Center finds that higher doses of 74 to 82 Gray (Gy) greatly reduce the risk that the cancer will spread later — even 8-10 years after treatment.

In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT.
"Both treatments demonstrated excellent PSA outcomes (biochemical control) after treatment," said Thomas N. Eade, MBChB, a fellow in the department of radiation oncology at Fox Chase Cancer Center. "The patients who received IMRT tended to be older, but even with that factor, IMRT was better tolerated."

Cedara has announced that it will demonstrate at RSNA its new C4 integration platform, a system that allows OEM companies to integrate clinical applications into existing solutions, responding to the need to unify multiple PACS installations across the enterprise.

David B. Nash, M.D., MBA, FACP and editor of the American Journal of Medical Quality will unveil a groundbreaking supplement with three peer-reviewed articles about hospital-acquired infections in the National Press Club (Murrow Room), 529 14th Street, NW, Washington, DC on November 20, from 10 a.m. to 11 a.m.

According to a report from Breast Center Salzburg published in the International Journal of Cancer, radiation administered during surgery, directly at the site of the excised tumor, greatly reduces the incidence of ipsilateral (same side) breast tumor recurrence. The findings were delivered by Dr. Felix Sedlmayer, chairman of Radiation Oncology at the University of Salzburg, on Oct. 8 at a special meeting of the European Chapter of the International Society of IORT.

According to the Fox Chase Cancer Center study presented at the recent 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, external-beam radiation therapy for early-stage breast cancer can be delivered safely and in a shorter course that eliminates as much as two weeks from conventional treatment.

According to the Fox Chase Cancer Center study presented at the recent 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, external-beam radiation therapy for early-stage breast cancer can be delivered safely and in a shorter course that eliminates as much as two weeks from conventional treatment.

An analysis by Fox Chase Cancer Center researchers sought to identify which treatment-related factors are more likely to avoid feeding-tube dependency in patients with head and neck cancers.
"Three-dimensional treatment planning appears to have a significant impact on improving quality of life by reducing feeding tube dependency," said medical intern Linna Li, M.D., who presented the results at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Philadelphia.

Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer, said the Radiation Therapy Oncology Group (RTOG) study’s lead author Andre A. Konski, M.D., M.B.A., M.A., a radiation oncologist and director of clinical research in Fox Chase Cancer Center's radiation oncology department.

New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now